Vanda Pharmaceuticals, Inc. (NASDAQ:VNDA)
CAPS Rating:
A biopharmaceutical company focused on the development and commercialization of clinical-stage drug candidates, with exclusive worldwide commercial rights to three product candidates in clinical development for various central nervous system disorders.
RSS Headlines
Fool UK
Recs
od